Evidence map›Paper›PMID 36703114›Full record

ArticleBMC bioinformatics2023

Gdaphen, R pipeline to identify the most important qualitative and quantitative predictor variables from phenotypic data.

Maria Del Mar Muñiz Moreno, Claire Gavériaux-Ruff, Yann Herault

Abstract read
In one paragraph

Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria Del Mar Muñiz MorenoUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, Institut de Génétique, Biologie Moléculaire Et Cellulaire (IGBMC), 1 Rue Laurent Fries, 67404, Illkirch Graffenstaden, France. munizmorenomariadelmar@gmail.com.
Claire Gavériaux-RuffUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, Institut de Génétique, Biologie Moléculaire Et Cellulaire (IGBMC), 1 Rue Laurent Fries, 67404, Illkirch Graffenstaden, France.
Yann HeraultUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, Institut de Génétique, Biologie Moléculaire Et Cellulaire (IGBMC), 1 Rue Laurent Fries, 67404, Illkirch Graffenstaden, France. herault@igbmc.fr.ORCID http://orcid.org/0000-0001-7049-6900

Funding

Agence Nationale de la recherche (FR) ANR-10-IDEX-0002-02Agence Nationale de la recherche (FR) ANR-10-INBS-07Agence Nationale de la recherche (FR) ANR-17-EURE-0023Agence Nationale de la recherche (FR) ANR 20-SFRI-0012Horizon 2020 Framework Programme 848077
6 · The paper itself

Abstract

backgroundIn individuals or animals suffering from genetic or acquired diseases, it is important to identify which clinical or phenotypic variables can be used to discriminate between disease and non-disease states, the response to treatments or sexual dimorphism. However, the data often suffers from low number of samples, high number of variables or unbalanced experimental designs. Moreover, several parameters can be recorded in the same test. Thus, correlations should be assessed, and a more complex statistical framework is necessary for the analysis. Packages already exist that provide analysis tools, but they are not found together, rendering the decision method and implementation difficult for non-statisticians.

resultWe present Gdaphen, a fast joint-pipeline allowing the identification of most important qualitative and quantitative predictor variables to discriminate between genotypes, treatments, or sex. Gdaphen takes as input behavioral/clinical data and uses a Multiple Factor Analysis (MFA) to deal with groups of variables recorded from the same individuals or anonymize genotype-based recordings. Gdaphen uses as optimized input the non-correlated variables with 30% correlation or higher on the MFA-Principal Component Analysis (PCA), increasing the discriminative power and the classifier's predictive model efficiency. Gdaphen can determine the strongest variables that predict gene dosage effects thanks to the General Linear Model (GLM)-based classifiers or determine the most discriminative not linear distributed variables thanks to Random Forest (RF) implementation. Moreover, Gdaphen provides the efficacy of each classifier and several visualization options to fully understand and support the results as easily readable plots ready to be included in publications. We demonstrate Gdaphen capabilities on several datasets and provide easily followable vignettes.

conclusionsGdaphen makes the analysis of phenotypic data much easier for medical or preclinical behavioral researchers, providing an integrated framework to perform: (1) pre-processing steps as data imputation or anonymization; (2) a full statistical assessment to identify which variables are the most important discriminators; and (3) state of the art visualizations ready for publication to support the conclusions of the analyses. Gdaphen is open-source and freely available at https://github.com/munizmom/gdaphen , together with vignettes, documentation for the functions and examples to guide you in each own implementation.

Indexed as

Random ForestAnimalsGenotypeLinear ModelsBootstrappingClinical dataDiscriminationGeneralized linear modelsImputationMachine learningModelPhenotypic dataPredictionRandom forestR package

Identifiers

PMID36703114
PMCPMC9878791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.